Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca AbfiledCriticalAstrazeneca Ab
Priority to UY29273ApriorityCriticalpatent/UY29273A1/en
Publication of UY29273A1publicationCriticalpatent/UY29273A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención proporciona compuestos de fórmula (I): en donde R1, R2, A, A1 y B son como se definieron en la memoria descriptiva; procedimientos para la preparación de los mismos; composiciones farmacéuticas que los contienen; un procedimiento para preparar las composiciones farmacéutica; y su utilización en terapia. Los compuestos son útiles como inhibidores de MMP.The invention provides compounds of formula (I): wherein R1, R2, A, A1 and B are as defined in the specification; procedures for preparing them; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and its use in therapy. The compounds are useful as MMP inhibitors.
UY29273A2005-12-202005-12-20
NEW HIDANTOIN DERIVATIVES, COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCESSES AND APPLICATIONS
UY29273A1
(en)